Patents by Inventor Yejin HWANG

Yejin HWANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for recommending color of home appliance and computer readable recording medium
    Patent number: 11978135
    Abstract: A method for recommending a color of a home appliance is provided. The method includes providing a plurality of panel graphic objects corresponding to each of a plurality of panels of the home appliance, providing a plurality of color graphic objects each representing a plurality of colors, receiving a selection for one of the plurality of color graphic objects, applying a color represented by the selected color graphic object to one of the plurality of panel graphic objects, and providing information on a color scheme corresponding to the color represented by the selected color graphic object.
    Type: Grant
    Filed: March 11, 2022
    Date of Patent: May 7, 2024
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Jidam Hong, Seongjun Kim, Sohee Kim, Jieun Kim, Hyejin Kim, Jaeyoung Ro, Soyoung Yun, Sunhye Lee, Yejin Jeon, Kibeom Hwang
  • SEMICONDUCTOR DEVICE, ELECTRONIC SYSTEM INCLUDING THE SAME, AND METHOD OF FABRICATING THE SAME
    Publication number: 20240130123
    Abstract: Disclosed are semiconductor devices, electronic systems including the same, and methods of fabricating the same. The semiconductor device comprises a first gate stack structure including a first dielectric pattern and a first conductive pattern that are alternately stacked with each other, a memory channel structure including a first memory portion that penetrates the first gate stack structure, a through contact including a first through portion at a level the same as a level of the first memory portion, and a connection contact including a first connection portion at a level the same as the level of the first memory portion and the level of the first through portion. A minimum width of the first memory portion is less than a minimum width of the first through portion and a minimum width of the first connection portion.
    Type: Application
    Filed: June 12, 2023
    Publication date: April 18, 2024
    Inventors: Yejin PARK, Seung Yoon KIM, Heesuk KIM, Hyeongjin KIM, Sehee JANG, Minsoo SHIN, Seungjun SHIN, Sanghun CHUN, Jeehoon HAN, Jae-Hwang SIM, Jongseon AHN
  • Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors
    Patent number: 11834467
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, a composition comprising the compound, methods of using the compound for the treatment of various disorders associated with HPK1, and methods of preparing these compounds.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: December 5, 2023
    Assignee: 1ST Biotherapeutics, Inc.
    Inventors: Jinhwa Lee, Suyeon Jo, Keonseung Lim, A Yeong Park, Gadhe Changdev Gorakshnath, Hwajung Nam, Yeonguk Jeon, Yejin Hwang, Jae Eun Kim, Misoon Kim, Seung Mook Lim
  • 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds
    Patent number: 11744824
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmaceutical composition comprising the compound, and a method for treating or preventing an inflammatory and autoimmune diseases, especially neuroinflammation diseases using the compound.
    Type: Grant
    Filed: September 14, 2021
    Date of Patent: September 5, 2023
    Assignee: 1ST Biotherapeutics, Inc.
    Inventors: Jinhwa Lee, Suyeon Jo, Keonseung Lim, A Yeong Park, Gadhe Changdev Gorakshnath, Hwajung Nam, Yeonguk Jeon, Yejin Hwang, Jae Eun Kim, Misoon Kim, Inyoung Yang
  • Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same
    Patent number: 11649255
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, a composition comprising the compound, methods of using the compound for the treatment of various disorders associated with HPK1, and methods of preparing these compounds.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: May 16, 2023
    Assignee: 1ST Biotherapeutics, Inc.
    Inventors: Jinhwa Lee, Suyeon Jo, Keonseung Lim, A Yeong Park, Gadhe Changdev Gorakshnath, Hwajung Nam, Yeonguk Jeon, Yejin Hwang, Jae Eun Kim, Misoon Kim, Seung Mook Lim
  • INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS USING SAME
    Publication number: 20220098219
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, a composition comprising the compound, methods of using the compound for the treatment of various disorders associated with HPK1, and methods of preparing these compounds.
    Type: Application
    Filed: September 27, 2021
    Publication date: March 31, 2022
    Inventors: Jinhwa LEE, Suyeon JO, Keonseung LIM, A Yeong PARK, Gadhe Changdev GORAKSHNATH, Hwajung NAM, Yeonguk JEON, Yejin HWANG, Jae Eun KIM, Misoon KIM, Seung Mook LIM
  • INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS USING SAME
    Publication number: 20220098193
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, a composition comprising the compound, methods of using the compound for the treatment of various disorders associated with HPK1, and methods of preparing these compounds.
    Type: Application
    Filed: September 27, 2021
    Publication date: March 31, 2022
    Inventors: Jinhwa LEE, Suyeon JO, Keonseung LIM, A Yeong PARK, Gadhe Changdev GORAKSHNATH, Hwajung NAM, Yeonguk JEON, Yejin HWANG, Jae Eun KIM, Misoon KIM, Seung Mook LIM
  • 2-AMINO-3-CARBONYL IMIDAZOPYRIDINE AND PYRAZOLOPYRIDINE COMPOUNDS
    Publication number: 20220087985
    Abstract: The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmaceutical composition comprising the compound, and a method for treating or preventing an inflammatory and autoimmune diseases, especially neuroinflammation diseases using the compound.
    Type: Application
    Filed: September 14, 2021
    Publication date: March 24, 2022
    Inventors: Jinhwa LEE, Suyeon JO, Keonseung LIM, A Yeong PARK, Gadhe Changdev GORAKSHNATH, Hwajung NAM, Yeonguk JEON, Yejin HWANG, Jae Eun KIM, Misoon KIM, Inyoung YANG